登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Science，2月7日，Scientists are racing to model the next moves of a coronavirus that is still hard to predict》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-09

  • Scientists are racing to model the next moves of a coronavirus that's still hard to predict

    By Jon CohenFeb. 7, 2020 , 6:15 PM

    Beyond China itself, Thailand is the country that most likely will have people who arrive at one of its airports with an infection by the novel coronavirus (2019-nCoV) that has sickened more than 30,000 people. So says the latest update of a global risk assessment model created by a team of researchers from the Humboldt University of Berlin and the Robert Koch Institute that relies on air travel data.

  • 原文来源：https://www.sciencemag.org/news/2020/02/scientists-are-racing-model-next-moves-coronavirus-thats-still-hard-predict
37浏览量
原文链接
相关报告

  • 《Ecological Modelling，6月20日，A Global-Scale Ecological Niche Model to Predict SARS-CoV-2 Coronavirus Infection Rate》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-06-22
    • A Global-Scale Ecological Niche Model to Predict SARS-CoV-2 Coronavirus Infection Rate Author links open overlay panelGianpaoloCoroa Show more https://doi.org/10.1016/j.ecolmodel.2020.109187 Abstract COVID-19 pandemic is a global threat to human health and economy that requires urgent prevention and monitoring strategies. Several models are under study to control the disease spread and infection rate and to detect possible factors that might favour them, with a focus on understanding the correlation between the disease and specific geophysical parameters. However, the pandemic does not present evident environmental hindrances in the infected countries. Nevertheless, a lower rate of infections has been observed in some countries, which might be related to particular population and climatic conditions.
    44浏览量
    原文链接

  • 《Science，7月23日，Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-07-28
    • Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody Zhe Lv1,8,*, Yong-Qiang Deng2,*, Qing Ye2,*, Lei Cao1,*, Chun-Yun Sun3,*, Changfa Fan4,*, Weijin Hua Science 23 Jul 2020: eabc5881 DOI: 10.1126/science.abc5881 Abstract The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in an unprecedented public health crisis. There are no approved vaccines or therapeutics for treating COVID-19. Here we reported a humanized monoclonal antibody, H014, efficiently neutralizes SARS-CoV-2 and SARS-CoV pseudoviruses as well as authentic SARS-CoV-2 at nM level by engaging the S receptor binding domain (RBD). Importantly, H014 administration reduced SARS-CoV-2 titers in the infected lungs and prevented pulmonary pathology in hACE2 mouse model. Cryo-EM characterization of the SARS-CoV-2 S trimer in complex with the H014 Fab fragment unveiled a novel conformational epitope, which is only accessible when the RBD is in open conformation. Biochemical, cellular, virological and structural studies demonstrated that H014 prevents attachment of SARS-CoV-2 to its host cell receptors. Epitope analysis of available neutralizing antibodies against SARS-CoV and SARS-CoV-2 uncover broad cross-protective epitopes. Our results highlight a key role for antibody-based therapeutic interventions in the treatment of COVID-19.
    73浏览量
    原文链接